Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications Portfolio News / Karina Tin June 17, 2021 Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications Read More »
Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI) Portfolio News / Karina Tin June 16, 2021 Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI) Read More »
Circle Pharma raises $66 Million in Series C Financing Portfolio News / Karina Tin June 16, 2021 Circle Pharma raises $66 Million in Series C Financing Read More »
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock Portfolio News / Karina Tin June 15, 2021 RAPT Therapeutics Announces Pricing of Public Offering of Common Stock Read More »
RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis Portfolio News / Karina Tin June 14, 2021 RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis Read More »
Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform Portfolio News / Karina Tin June 10, 2021 Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform Read More »
eFFECTOR Therapeutics Doses First Patient in Phase 2b KICKSTART Clinical Trial Portfolio News / Karina Tin June 9, 2021 eFFECTOR Therapeutics Doses First Patient in Phase 2b KICKSTART Clinical Trial Read More »
Ribon Therapeutics Announces Oral Presentation of Positive Interim Data from Phase 1 Trial of RBN-2397 in Patients with Advanced Solid Tumors at 2021 ASCO Annual Meeting Portfolio News / Karina Tin June 4, 2021 Ribon Therapeutics Announces Oral Presentation of Positive Interim Data from Phase 1 Trial of RBN-2397 in Patients with Advanced Solid Tumors at 2021 ASCO Annual Meeting Read More »
ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel Portfolio News / Karina Tin June 02, 2021 ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel Read More »
Constellation Pharmaceuticals to be Acquired by MorphoSys Portfolio News / Karina Tin June 2, 2021 Constellation Pharmaceuticals to be Acquired by MorphoSys Read More »